Kshitij Srivastava

Kshitij Srivastava is a seasoned Immuno-Oncologist with a passion for Business Development, boasting expertise in NGS, Biomarker, and CDx solutions for Clinical Immuno-Oncology.

With over 7 years of experience in translational oncology research, Kshitij holds an exceptional publication record with lead author contributions in prestigious journals such as 'Cancer Cell' and 'Science'.

His professional journey includes project leadership roles in major biotech companies, where he effectively managed interdisciplinary drug discovery teams.

Kshitij Srivastava excels in building strong relationships within the Oncology Key Opinion Leader (KOL) network and demonstrates proficiency in networking, business development, and scientific sales.

His educational background is highly diverse, encompassing studies in Business Administration, Pharmacy, Biology, Genetics, and Veterinary Science from renowned institutions like Ucl, Dkfz German Cancer Research Center, Karolinska Institutet, and Heidelberg University.

His professional experience includes roles at esteemed organizations such as Bayer, Personalis, Inc., Novoptim, Evotec, Merck Serono, and the Dkfz German Cancer Research Center, where he served as a Helmholtz Postdoctoral Fellow and a Graduate Student.

Moreover, Kshitij's skills extend to Strategy and Business Consulting, Field Application Science, and Research in In Vivo Pharmacology, culminating in a well-rounded professional profile.

Kshitij Srivastava's innate curiosity and expertise make him a valuable asset in the field of Immuno-Oncology and Business Development.